Peer-influenced content. Sources you trust. No registration required. This is HCN.

The New England Journal of MedicinePsilocybin in Treatment-Resistant Depression

“Because medicine abhors a therapeutic vacuum,” the hallucinogens psilocybin and LSD are being revisited as potential candidates for treating depression. But effect size seems less than that of currently approved antidepressants.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form